Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Abstract Session

Periodic Fever Syndromes, Autoinflammatory Diseases, Still’s Disease and MAS/HLH
General Topic: Clinical Science

27M36: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases II: Models and Mechanisms (1662–1667)

Monday, October 27, 2025
1:00 PM - 2:30 PM Central Time
Location: S102
CE: 0.00

Non-CME In Person On Demand

    Abstract Moderator(s)

  • JG

    Jorge Gonzalez Chapa, MD, PhD

    University of Washington
    Seattle, Washington, United States

    Disclosure information not submitted.

  • LJ

    Lakshmi Jayaram, MD

    Stanford University
    Palo Alto, California, United States

    Disclosure(s): No financial relationships with ineligible companies to disclose

Please note: This session is not eligible for CME Credits.

Presentations:

  • 1:00 PM - 1:15 PM Central Time
    Efficacy and Safety of Nerandomilast in Patients with Autoimmune Disease-Related Progressive Pulmonary Fibrosis: Subgroup Analysis of the FIBRONEER-ILD trial

    Presenting Author: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital

  • 1:15 PM - 1:30 PM Central Time
    Tocilizumab for acute exacerbation of rheumatic disease-related interstitial lung disease: A prospective real-world study

    Presenting Author: Wenwen Xu, MD (she/her/hers) – Shanghai Jiaotong University Affiliated Ruijin Hospital

  • 1:30 PM - 1:45 PM Central Time
    Cardiac Sarcoidosis Response to Steroid-Sparing Immunosuppression

    Presenting Author: Matthew Baker, MD, MS – Stanford University

  • 1:45 PM - 2:00 PM Central Time
    Comparative Effectiveness of Biologic Versus Conventional Therapy in Uveitis with Systemic Rheumatic Diseases: Real-World Evidence from a Propensity-Matched Cohort

    Presenting Author: Hanieh Akbari, MD – Jefferson Einstein Montgomery Medical Center

  • 2:00 PM - 2:15 PM Central Time
    Treatment with Rilzabrutinib was associated with Rapid and Sustained Reduction in Disease Activity in Patients with IgG4-RD Previously Treated or Naïve to B cell Depletion

    Presenting Author: John Stone, MD, MPH – Massachusetts General Hospital , Harvard Medical School

  • 2:15 PM - 2:30 PM Central Time
    Recurrent or Incident Pericarditis With Concurrent Autoimmune Disease: Stable Control With Rilonacept Interleukin-1 Pathway Inhibition

    Presenting Author: Zachary Daniel, MD (he/him/his) – Albany Medical College